Elicitation of neutralizing antibodies with DNA vaccines expressing soluble stabilized human immunodeficiency virus type 1 envelope glycoprotein trimers conjugated to C3d

被引:70
作者
Bower, JF
Yang, XZ
Sodroski, J
Ross, TM
机构
[1] Univ Pittsburgh, Sch Med, Dept Med, Div Infect Dis, Pittsburgh, PA 15261 USA
[2] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Div Aids, Boston, MA 02115 USA
关键词
D O I
10.1128/JVI.78.9.4710-4719.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
DNA vaccines expressing the envelope (Env) of human immunodeficiency virus type I (HIV-1) have been relatively ineffective at generating high-titer, long-lasting immune responses. Oligomeric or trimeric (gp140) forms of Env that more closely mimic the native proteins on the virion are often more effective immunogens than monomeric (gp120) envelopes. In this study, several forms of Env constructed from the HIV-1 isolate YU-2 (HIV-1(YU-2)) were tested for their immunogenic potential: a trimeric form of uncleaved (-) Env stabilized with a synthetic trimer motif isolated from the fibritin (IT) protein of the T4 bacteriophage, sgp140(YU-2)(-/FT), was compared to sgp140(YU)-2(-) without a synthetic trimerization domain, as well as to monomeric gp120(YU)-2. DNA plasmids were constructed to express Env alone or fused to various copies of murine C3d (mCM). BALB/c mice were vaccinated (day 1 and week 4) with DNA expressing a codon-optimized envelope gene insert, alone or fused to mC3d. Mice were subsequently boosted (week 8) with the DNA or recombinant Env protein. All mice had high anti-Env antibody titers regardless of the use of mC3d. Sera from mice vaccinated with DNA expressing non-C3d-fused trimers elicited neutralizing antibodies against homologous HIV-1(YU-2) virus infection in vitro. In contrast, sera from mice inoculated with DNA expressing Env-C3d protein trimers elicited antibody that neutralized both homologous HIV-1(YU-2) and heterologous RIV-1(ADA), albeit at low titers. Therefore, DNA vaccines expressing trimeric envelopes coupled to mC3d, expressed in vivo from codon-optimized sequences, elicit low titers of neutralizing antibodies against primary isolates of HIV-1.
引用
收藏
页码:4710 / 4719
页数:10
相关论文
共 69 条
  • [1] André S, 1998, J VIROL, V72, P1497
  • [2] The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable region
    Barnet, SW
    Lu, S
    Srivastava, I
    Cherpelis, S
    Gettie, A
    Blanchard, J
    Wang, S
    Mboudjeka, I
    Leung, L
    Lian, Y
    Fong, A
    Buckner, C
    Ly, A
    Hilt, S
    Ulmer, J
    Wild, CT
    Mascola, JR
    Stamatatos, L
    [J]. JOURNAL OF VIROLOGY, 2001, 75 (12) : 5526 - 5540
  • [3] PROTECTION OF CHIMPANZEES FROM INFECTION BY HIV-1 AFTER VACCINATION WITH RECOMBINANT GLYCOPROTEIN GP120 BUT NOT GP160
    BERMAN, PW
    GREGORY, TJ
    RIDDLE, L
    NAKAMURA, GR
    CHAMPE, MA
    PORTER, JP
    WURM, FM
    HERSHBERG, RD
    COBB, EK
    EICHBERG, JW
    [J]. NATURE, 1990, 345 (6276) : 622 - 625
  • [4] A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure
    Binley, JM
    Sanders, RW
    Clas, B
    Schuelke, N
    Master, A
    Guo, Y
    Kajumo, F
    Anselma, DJ
    Maddon, PJ
    Olson, WC
    Moore, JP
    [J]. JOURNAL OF VIROLOGY, 2000, 74 (02) : 627 - 643
  • [5] CD21 augments antigen presentation in immune individuals
    Boackle, SA
    Holers, VM
    Karp, DR
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (01) : 122 - 129
  • [6] Impact of codon usage modification on T cell immunogenicity and longevity of HIV-1 gag-specific DNA vaccines
    Bojak, A
    Wild, J
    Deml, L
    Wagner, R
    [J]. INTERVIROLOGY, 2002, 45 (4-6) : 275 - 286
  • [7] ANTIGENIC IMPLICATIONS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE QUATERNARY STRUCTURE - OLIGOMER-SPECIFIC AND OLIGOMER-SENSITIVE MONOCLONAL-ANTIBODIES
    BRODER, CC
    EARL, PL
    LONG, D
    ABEDON, ST
    MOSS, B
    DOMS, RW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (24) : 11699 - 11703
  • [8] CARTER RH, 1988, J IMMUNOL, V141, P457
  • [9] Modifications of the human immunodeficiency virus envelope glycoprotein enhance immunogenicity for genetic immunization
    Chakrabarti, BK
    Kong, W
    Wu, B
    Yang, ZY
    Friborg, J
    Ling, X
    King, SR
    Montefiori, DC
    Nabel, GJ
    [J]. JOURNAL OF VIROLOGY, 2002, 76 (11) : 5357 - 5368
  • [10] Core structure of gp41 from the HIV envelope glycoprotein
    Chan, DC
    Fass, D
    Berger, JM
    Kim, PS
    [J]. CELL, 1997, 89 (02) : 263 - 273